Valuable Targets

Demystifying H2 receptor antagonists: A Comprehensive Guide and How to Keep Up with the Latest Developments

2 January 2024
4 min read

The H2 receptor, also known as the histamine H2 receptor, plays a crucial role in the human body. It is primarily found in the stomach lining and is responsible for regulating the production of gastric acid. Activation of the H2 receptor by histamine leads to an increase in acid secretion, which aids in the digestion of food. However, excessive acid production can lead to conditions like gastric ulcers and gastroesophageal reflux disease (GERD). Therefore, pharmaceutical companies have developed H2 receptor antagonists, commonly known as H2 blockers, to inhibit the receptor's activity and reduce acid secretion, providing relief from acid-related disorders.

Looking forward, the future of H2 receptor antagonists appears promising. Recent studies suggest that H2 receptor antagonists show significant promise as radioprotective agents. They could potentially be used for providing partial protection against radiation injury. Furthermore, there is ongoing research into repurposing H2 receptor antagonists for other uses. The global H2-receptor antagonists market is anticipated to grow at a substantial CAGR in the upcoming years. These developments suggest that H2 receptor antagonists could play a significant role in the treatment of various diseases in the future.

The analysis of the target H2 receptor reveals a competitive landscape with multiple companies focusing on the development of drugs for various indications related to gastrointestinal disorders. GSK Plc is leading in terms of the highest number of drugs in the approved stage. Small molecule drugs are the most common drug type, indicating intense competition. China, the United States, Japan, and South Korea are the countries/locations with the highest development progress. China, in particular, has made significant progress in the development of drugs for the target H2 receptor. The future development of the target H2 receptor is expected to continue with a focus on innovative small molecule drugs and biosimilars, particularly in the treatment of gastrointestinal disorders.

How do they work?

H2 receptor antagonists, also known as H2 blockers, are a class of drugs that inhibit the action of histamine on the H2 receptors in the stomach. Histamine is a chemical released by cells in the stomach lining and stimulates the production of stomach acid. By blocking the H2 receptors, H2 receptor antagonists reduce the production of stomach acid, thereby decreasing acid-related symptoms and promoting healing of certain gastrointestinal conditions.

From a biomedical perspective, H2 receptor antagonists are commonly used in the treatment of conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis. These drugs help alleviate symptoms like heartburn, acid reflux, and stomach pain by reducing the amount of acid produced in the stomach. They are often prescribed as a first-line treatment for these conditions and are available both over-the-counter and by prescription.

Examples of H2 receptor antagonists include famotidine, ranitidine, and cimetidine. These drugs work by binding to the H2 receptors on the surface of stomach cells, preventing histamine from binding and triggering acid production. By reducing gastric acid secretion, H2 receptor antagonists provide relief from acid-related symptoms and promote the healing of damaged stomach lining.

It's important to note that while H2 receptor antagonists are effective in managing certain gastrointestinal conditions, they may not be suitable for everyone. Individuals with certain medical conditions or taking specific medications should consult with their healthcare provider before using H2 receptor antagonists. Additionally, prolonged use of these drugs may have some side effects, such as headaches, dizziness, and diarrhea. Therefore, it is essential to follow the recommended dosage and duration of treatment as advised by a healthcare professional.

List of H2 receptor Antagonists

The currently marketed H2 receptor antagonists include:

For more information, please click on the image below.

图形用户界面, 应用程序

描述已自动生成

What are H2 receptor antagonists used for?

H2 receptor antagonists are commonly used in the treatment of conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis.  For more information, please click on the image below to log in and search.

图形用户界面, 表格

描述已自动生成

How to obtain the latest development progress of H2 receptor antagonists?

In the Synapse database, you can keep abreast of the latest research and development advances of H2 receptor antagonists anywhere and anytime, daily or weekly, through the "Set Alert" function. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 应用程序, Teams

描述已自动生成

Mineralys Therapeutics Announces First Patient Dosed in Start-HTN, Its Second Key Trial of Lorundrostat for Hypertension Control
Latest Hotspot
3 min read
Mineralys Therapeutics Announces First Patient Dosed in Start-HTN, Its Second Key Trial of Lorundrostat for Hypertension Control
2 January 2024
Mineralys Therapeutics Reports Initial Participant Receives Dose in Start-HTN, Their Second Major Study of Lorundrostat Aimed at Hypertension Management.
Read →
Jazz Pharmaceuticals Releases Information on Stage 2 Research for Experimental JZP150 in Adults Suffering from PTSD
Latest Hotspot
3 min read
Jazz Pharmaceuticals Releases Information on Stage 2 Research for Experimental JZP150 in Adults Suffering from PTSD
2 January 2024
Jazz Pharmaceuticals plc announced early results from its Phase 2 trial evaluating the efficacy and safety of JZP150, a selective FAAH enzyme inhibitor, in adults with PTSD.
Read →
How does pH affect drug delivery?
Knowledge Base
3 min read
How does pH affect drug delivery?
2 January 2024
Drug delivery can be significantly affected by the pH of the environment in which it occurs.
Read →
The FDA approved updated packaging for Kite Pharma's Yescarta® with survival rate information
Latest Hotspot
3 min read
The FDA approved updated packaging for Kite Pharma's Yescarta® with survival rate information
2 January 2024
The FDA has sanctioned an update to the packaging of Kite Pharma's Yescarta® treatment, now incorporating information on patient survival rates.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.